Zhang Chengcheng Christine, Kantowski Marcus, Wehling Cyrill, Michl Patrick, Koschny Ronald, Sauer Peter
Department of Gastroenterology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.
BMC Gastroenterol. 2025 Jun 4;25(1):431. doi: 10.1186/s12876-025-04053-0.
Malignant hilar biliary obstruction is associated with a poor prognosis, making biliary drainage important for improving the quality of life. Endoscopic simultaneous side-by-side deployment of uncovered self-expandable metal stents is a novel approach. However, reliable clinical data on this method are limited. This retrospective, single-center study aimed to evaluate the feasibility, effectiveness, and safety of simultaneous side-by-side deployment of self-expandable metal stents for malignant hilar biliary obstruction.
Data from all patients treated for malignant hilar biliary obstruction at our institution between May 2019 and February 2023 were retrospectively analyzed. The primary endpoints were the technical and clinical success rates, while the secondary endpoints included complications, recurrent biliary obstruction, time to recurrent obstruction, reintervention rate, and mortality.
Fifteen patients (mean age, 63 years; 8 men) were treated with simultaneous side-by-side deployment of metal stents for malignant hilar biliary obstruction. The location of the biliary obstruction was classified as Bismuth type III (n = 1) or IV (n = 14). Technical and clinical success rates were both 100%. Three patients underwent side-by-side placement of uncovered self-expandable metal stents using the combined percutaneous endoscopic rendezvous technique. The complication rate was 13.3%, with two patients experiencing recurrent biliary obstruction and cholangitis. The median time to recurrent obstruction was 97.5 days (range: 93-102 days). Both patients required reintervention. Moreover, the 30-day mortality rate was 6.7% (n = 1).
Endoscopic simultaneous side-by-side deployment of uncovered self-expandable metal stents for unresectable malignant hilar biliary obstruction is feasible and safe, with high success rates. This technique not only effectively controls symptoms through successful biliary drainage, but can also be a promising option for complex anatomic situations when combined with the percutaneous endoscopic rendezvous technique.
恶性肝门部胆管梗阻预后较差,胆管引流对于改善生活质量至关重要。内镜下同时并排置入无覆膜自膨式金属支架是一种新方法。然而,关于该方法可靠的临床数据有限。这项回顾性单中心研究旨在评估同时并排置入自膨式金属支架治疗恶性肝门部胆管梗阻的可行性、有效性和安全性。
回顾性分析2019年5月至2023年2月在本机构接受治疗的所有恶性肝门部胆管梗阻患者的数据。主要终点为技术成功率和临床成功率,次要终点包括并发症、复发性胆管梗阻、复发梗阻时间、再次干预率和死亡率。
15例患者(平均年龄63岁;8例男性)接受了同时并排置入金属支架治疗恶性肝门部胆管梗阻。胆管梗阻部位分为Bismuth III型(n = 1)或IV型(n = 14)。技术成功率和临床成功率均为100%。3例患者采用经皮内镜会师技术同时并排置入无覆膜自膨式金属支架。并发症发生率为13.3%,2例患者出现复发性胆管梗阻和胆管炎。复发梗阻的中位时间为97.5天(范围:93 - 102天)。2例患者均需要再次干预。此外,30天死亡率为6.7%(n = 1)。
内镜下同时并排置入无覆膜自膨式金属支架治疗不可切除的恶性肝门部胆管梗阻是可行且安全的,成功率高。该技术不仅通过成功的胆管引流有效控制症状,而且在与经皮内镜会师技术联合使用时,对于复杂解剖情况也可能是一种有前景的选择。